Comparison

Recombinant Human VEGF165/VEGFA Protein

Item no. ELS-PKSH033475-10ug
Manufacturer Elabscience
Amount 10 ug
Quantity options 10 ug 50 ug
Category
Type Proteins
Format Lyophilized Powder
Applications ELISA
Specific against Human (Homo sapiens)
Host HEK293 cells
Conjugate/Tag Untagged
Purity > 95 % as determined by reducing SDS-PAGE.
Sequence Ala27-Arg191
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias MVCD1, VEGF, VEGF165, VPF, Vascular Endothelial Growth Factor Isoform 165
Similar products VEGF, VEGF165, VPF, MVCD1, Vascular Endothelial Growth Factor Isoform 165
Shipping Condition Cool pack
Available
Manufacturer - Category
Recombinant Proteins / Cytokines
Manufacturer - Conjugate / Tag
None
Shipping Temperature
This product is provided as lyophilized powder which is shipped with ice packs.
Storage Conditions
Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
Calculated Molecular Weight
19.1 kDa
Observed Molecular Weight
18-22 kDa
Manufacturer - Research Areas
Cardiovascular, Signal Transduction, Cancer, Developmental Biology, Kits, Lysates, Other, Metabolism
Background
Human Vascular endothelial growth factor (VEGF); also known as VEGF-A and vascular permeability factor (VPF); belongs to the platelet-derived growth factor family of cysteine-knot growth factors. It is a potent activator in vasculogenesis and angiogenesis both physiologically and pathologically. VEGF-A has 8 differently spliced isoforms; of which VEGF165 is the most abundant one. VEGF165 is a disulfide-linked homodimer consisting of two glycosylated 165 amino acid polypeptide chains. VEGF stimulates the cellular response through binding to tyrosine kinase receptors VEGFR1 and VEGFR2 on the cell surface. It is widely accepted that VEGFR2 mediate almost all of the known cellular responses to VEGF while the function of VEGFR1 is less defined and is thought to modulate the VEGFR2 signaling.
Abbreviation
VEGF165; VEGFA
Endotoxin
< 0.01 EU per μg of the protein as determined by the LAL method.
Reconstitution
Please refer to the printed manual for detailed information.
Formulation
Lyophilized from a 0.2 μm filtered solution of 20mM Citrate, 8% Sucrose, 4% Mannitol, 0.05% Tween 80, pH4.0.
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Activity
Immobilized Human VEGF165 at 2μg/ml (100 μl/well) can bind Human VEGF-A antibody. The ED50 of Human VEGF-A antibody is 2.20 ng/ml.
Protein Construction
Recombinant Human VEGF165 is produced by our Mammalian expression system and the target gene encoding Ala27-Arg191 is expressed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?